Submitted by fdagov3951 in business
The FDA approved Wezlana as an interchangeable biosimilar to Stelara for multiple inflammatory diseases.
Submitted by fdagov3951 in business
The FDA approved Wezlana as an interchangeable biosimilar to Stelara for multiple inflammatory diseases.